{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:59:06Z","timestamp":1759334346122,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2003]]},"DOI":"10.1078\/0171-2985-00208","type":"journal-article","created":{"date-parts":[[2005,8,18]],"date-time":"2005-08-18T08:36:58Z","timestamp":1124354218000},"page":"47-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome"],"prefix":"10.1078","volume":"207","author":[{"given":"Aviva","family":"Katzav","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amos D.","family":"Korczyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miri","family":"Blank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joab","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1078\/0171-2985-00208_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0167-5699(95)80134-0","article-title":"The regulation and function of p21ras during T-cell activation and growth","volume":"16","author":"Pastor","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1078\/0171-2985-00208_bib2","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0925-4439(97)00077-X","article-title":"Stringent structural requirements for anti-Ras activity of Sprenyl analogues","volume":"1406","author":"Aharonson","year":"1998","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1078\/0171-2985-00208_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1046\/j.1365-2249.2001.01674.x","article-title":"Treatment of MRL\/lpr mice, a genetic autoimmune model, with the Ras inhibitor, farnesylthiosalicylate (FTS)","volume":"126","author":"Katzav","year":"2001","journal-title":"Clin. Exp. Immunol."},{"key":"10.1078\/0171-2985-00208_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(01)00385-X","article-title":"The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis","volume":"120","author":"Karussis","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1078\/0171-2985-00208_bib5","first-page":"122","article-title":"Treatment of experimental autoimmune neuritis by a Ras inhibitor, s-farnesylthiosalicylic acid (FTS)","volume":"48","author":"Kafri","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1078\/0171-2985-00208_bib6","first-page":"890","article-title":"Pathogenic potential of antiphospholipid antibodies","volume":"15","author":"Alarcon-Segovia","year":"1988","journal-title":"J. Rheumatol."},{"key":"10.1078\/0171-2985-00208_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1191\/096120301678416060","article-title":"Hyperactivity in a mouse model of the antiphospholipid syndrome","volume":"10","author":"Katzav","year":"2001","journal-title":"Lupus"},{"key":"10.1078\/0171-2985-00208_bib8","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1161\/01.CIR.97.9.900","article-title":"Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome","volume":"97","author":"George","year":"1998","journal-title":"Circulation"},{"key":"10.1078\/0171-2985-00208_bib9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/cimm.1994.1057","article-title":"Effects of early and late treatment with anti- CD4 monoclonal antibody on autoimmune disease in MRL\/MP-lpr\/lpr mice","volume":"154","author":"Jabs","year":"1994","journal-title":"Cell. Immunol."},{"key":"10.1078\/0171-2985-00208_bib10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-2999(01)01555-2","article-title":"Weekly pulse therapy of methotrexate improves survival compared with its daily administration in MRL\/lpr mice","volume":"435","author":"Asanuma","year":"2002","journal-title":"Eur. J. Pharmacol."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298504701631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298504701631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:18:41Z","timestamp":1759249121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298504701631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003]]}},"alternative-id":["S0171298504701631"],"URL":"https:\/\/doi.org\/10.1078\/0171-2985-00208","relation":{},"ISSN":["0171-2985"],"issn-type":[{"type":"print","value":"0171-2985"}],"subject":[],"published":{"date-parts":[[2003]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1078\/0171-2985-00208","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Urban & Fischer Verlag. Published by Elsevier GmbH All rights reserved.","name":"copyright","label":"Copyright"}]}}